Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 4,692,000 | 4,329,000 | 5,206,000 | 4,508,000 | 4,493,000 |
| Cost of Goods | 1,054,000 | 1,153,000 | 1,265,000 | 1,014,000 | 1,073,000 |
| Gross Profit | 3,638,000 | 3,176,000 | 3,941,000 | 3,494,000 | 3,420,000 |
| Operating Expenses | 2,185,000 | 1,871,000 | 2,120,000 | 1,898,000 | 1,998,000 |
| Operating Income | 1,453,000 | 1,305,000 | 1,821,000 | 1,596,000 | 1,422,000 |
| Interest Expense | 75,000 | 66,000 | 88,000 | -1,000 | -2,000 |
| Other Income | -10,000 | 0 | -20,000 | 7,000 | -22,000 |
| Pre-tax Income | 1,368,000 | 1,239,000 | 1,713,000 | 1,604,000 | 1,402,000 |
| Income Tax | 300,000 | 271,000 | 173,000 | 19,000 | 135,000 |
| Net Income Continuous | 1,068,000 | 968,000 | 1,540,000 | 1,585,000 | 1,267,000 |
| Net Income | $1,068,000 | $968,000 | $1,540,000 | $1,585,000 | $1,267,000 |
| EPS Basic Total Ops | 0.67 | 0.61 | 0.98 | 1.01 | 0.80 |
| EPS Basic Continuous Ops | 0.67 | 0.61 | 0.98 | 1.01 | 0.80 |
| EPS Diluted Total Ops | 0.66 | 0.60 | 0.98 | 1.01 | 0.80 |
| EPS Diluted Continuous Ops | 0.66 | 0.60 | 0.98 | 1.01 | 0.80 |
| EBITDA(a) | $1,689,000 | $1,532,000 | $2,130,000 | $1,823,000 | $1,717,000 |